title: Vivo-morpholinos induced transient knockdown of physical activity related proteins.
abstract: Physical activity is associated with disease prevention and overall wellbeing. Additionally there has been evidence that physical activity level is a result of genetic influence. However, there has not been a reliable method to silence candidate genes in vivo to determine causal mechanisms of physical activity regulation. Vivo-morpholinos are a potential method to transiently silence specific genes. Thus, the aim of this study was to validate the use of Vivo-morpholinos in a mouse model for voluntary physical activity with several sub-objectives. We observed that Vivo-morpholinos achieved between 60-97% knockdown of Drd1-, Vmat2-, and Glut4-protein in skeletal muscle, the delivery moiety of Vivo-morpholinos (scramble) did not influence physical activity and that a cocktail of multiple Vivo-morpholinos can be given in a single treatment to achieve protein knockdown of two different targeted proteins in skeletal muscle simultaneously. Knocking down Drd1, Vmat2, or Glut4 protein in skeletal muscle did not affect physical activity. Vivo-morpholinos injected intravenously alone did not significantly knockdown Vmat2-protein expression in the brain (p = 0.28). However, the use of a bradykinin analog to increase blood-brain-barrier permeability in conjunction with the Vivo-morpholinos significantly (p = 0.0001) decreased Vmat2-protein in the brain with a corresponding later over-expression of Vmat2 coincident with a significant (p = 0.0016) increase in physical activity. We conclude that Vivo-morpholinos can be a valuable tool in determining causal gene-phenotype relationships in whole animal models.
authors: Department of Health and Kinesiology, Texas A&M University, College Station, Texas, United States of America. davidpferguson13@gmail.com
authors: David P
authors: DP
authors: Ferguson
authors: Emily E
authors: EE
authors: Schmitt
authors: J Timothy
authors: JT
authors: Lightfoot
mesh_terms: D000818:Animals; D055785:Gene Knockdown Techniques; D051275:Glucose Transporter Type 4 / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D060172:Morpholinos / Q000235:genetics*; D009043:Motor Activity / Q000235:genetics*; D018482:Muscle, Skeletal / Q000378:metabolism; D009714:Nucleus Accumbens / Q000378:metabolism; D009928:Organ Specificity; D017447:Receptors, Dopamine D1 / Q000235:genetics / Q000378:metabolism; D012420:Running; D050493:Vesicular Monoamine Transport Proteins / Q000235:genetics
chemical_list: D051275:Glucose Transporter Type 4; D060172:Morpholinos; D017447:Receptors, Dopamine D1; C493453:Slc18a2 protein, mouse; C495693:Slc2a4 protein, mouse; D050493:Vesicular Monoamine Transport Proteins
references: Neuroscience. 2011 Jan 13;172:329-41
references: 20951776
references: J Neurosci. 2009 Jun 24;29(25):8103-13
references: 19553450
references: FASEB J. 2010 Sep;24(9):3462-7
references: 20460584
references: Curr Opin Mol Ther. 2006 Apr;8(2):93-103
references: 16610760
references: J Exp Biol. 2011 Jan 15;214(Pt 2):254-62
references: 21177945
references: PLoS One. 2011;6(11):e27395
references: 22076157
references: Brain Res. 2007 Jun 4;1152:10-6
references: 17433807
references: Cell Biosci. 2011 Sep 06;1(1):30
references: 21896185
references: Nature. 2011 Oct 05;478(7367):127-31
references: 21979053
references: Mol Ther. 2011 Jan;19(1):159-64
references: 20924365
references: Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84
references: 22006329
references: Mol Cell Biol. 2012 Jun;32(11):2044-53
references: 22473990
references: Behav Brain Res. 2009 Dec 1;204(1):147-52
references: 19520120
references: PLoS One. 2012;7(3):e33576
references: 22438952
references: J Neurosci. 2009 Apr 8;29(14):4592-604
references: 19357284
references: BMC Musculoskelet Disord. 2011 Jan 26;12:27
references: 21269506
references: Blood Cells Mol Dis. 2010 Dec 15;45(4):326-33
references: 21035359
references: FASEB J. 2001 Apr;15(6):958-69
references: 11292656
references: Eur J Pharmacol. 2009 Jan 14;602(2-3):306-15
references: 19038246
references: Int J Biol Sci. 2010 Mar 09;6(2):133-50
references: 20224735
references: Med Sci Sports Exerc. 2008 Jan;40(1):181-8
references: 18091006
references: Clin Pharmacokinet. 2001;40(2):105-23
references: 11286321
references: PLoS One. 2011;6(6):e20677
references: 21677777
references: PLoS One. 2011;6(5):e19906
references: 21611204
references: Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G182-93
references: 21979757
references: Diabetes. 2012 May;61(5):1090-9
references: 22403297
references: J Nutr. 2011 Mar;141(3):526-30
references: 21270357
references: Am J Physiol Regul Integr Comp Physiol. 2010 Oct;299(4):R1044-9
references: 20668235
references: Sci Rep. 2012;2:347
references: 22470840
references: J Biol Chem. 2011 Feb 25;286(8):6033-9
references: 21156798
references: J Neurosci. 2012 Mar 7;32(10):3563-74
references: 22399778
references: Curr Pharm Des. 2008;14(25):2619-34
references: 18991679
references: Parkinsons Dis. 2011 Feb 21;2011:124165
references: 21403896
references: Stem Cells. 2010 Nov;28(11):2073-83
references: 20872846
references: PLoS One. 2011;6(12):e29462
references: 22216285
references: J Neurosci Methods. 2012 Jan 30;203(2):354-60
references: 22027492
references: Mol Cell Neurosci. 2011 Sep;48(1):29-37
references: 21699982
references: J Appl Physiol (1985). 2001 Mar;90(3):1137-57
references: 11181630
references: Behav Brain Funct. 2005 Jul 15;1:9
references: 16022733
references: Psychopharmacology (Berl). 2007 Jul;193(1):55-62
references: 17377774
references: PLoS Negl Trop Dis. 2010 Nov 23;4(11):e892
references: 21124882
references: J Appl Physiol (1985). 2010 Sep;109(3):623-34
references: 20538847
references: JAMA. 2004 Mar 10;291(10):1238-45
references: 15010446
references: Genes Brain Behav. 2011 Mar;10(2):186-98
references: 20860702
references: Biotechniques. 2008 Dec;45(6):613-4, 616, 618 passim
references: 19238792
references: Dev Biol. 2011 Jun 15;354(2):221-31
references: 21497156
references: J Pharmacol Exp Ther. 1994 Oct;271(1):229-37
references: 7965719
references: Neuropeptides. 2008 Aug;42(4):423-34
references: 18533255
references: Eur J Neurosci. 2006 Nov;24(9):2622-30
references: 17100850
references: J Neurosci. 2012 Mar 28;32(13):4623-31
references: 22457508
references: Blood Cells Mol Dis. 2010 Mar 15;44(3):169-74
references: 20045356
references: PLoS Genet. 2008 Feb;4(2):e34
references: 18282110
references: Mol Ther. 2009 May;17(5):864-71
references: 19277018
references: Gut. 2010 Oct;59(10):1316-30
references: 20732914
references: Sci Transl Med. 2011 Oct 26;3(106):106ra107
references: 22030750
references: Muscle Nerve. 2011 Oct;44(4):563-70
references: 21922468
references: Am J Physiol. 1995 Mar;268(3 Pt 1):E514-20
references: 7900797
references: J Physiol. 2007 Jul 15;582(Pt 2):801-12
references: 17495042